{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:44:43Z","timestamp":1795106683347,"version":"4.10.3"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>\n                    The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the etiology and risk factors, histologic classification and subtypes, malignant progression risks, prevention options, and to outline both surgical and nonsurgical treatment options. Abnormal uterine and postmenopausal bleeding remain the hallmark of endometrial pathology, and up to 10\u201320% of postmenopausal bleeding will be either hyperplasia or cancer; thus, immediate evaluation of any abnormal bleeding with either tissue procurement for pathology or imaging should be undertaken. Although anyone with a uterus may develop atypical hyperplasia, also known as\n                    <jats:italic toggle=\"yes\">endometrial intraepithelial neoplasia<\/jats:italic>\n                    (EIN), genetic predispositions (eg, Lynch syndrome), obesity, chronic anovulation, and polycystic ovarian syndrome all markedly increase these risks, whereas use of oral contraceptive pills or progesterone-containing intrauterine devices will decrease the risk. An EIN diagnosis carries a high risk of concomitant endometrial cancer or eventual progression to cancer in the absence of treatment. The definitive and curative treatment for EIN remains hysterectomy; however, the obesity epidemic, the potential desire for fertility-sparing treatments, the recognition of varying rates of malignant transformation, medical comorbidities, and an aging population all may factor into decisions to employ nonsurgical treatment modalities.\n                  <\/jats:p>","DOI":"10.1097\/aog.0000000000004989","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:42Z","timestamp":1668124842000},"page":"1061-1075","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":110,"title":["Endometrial Hyperplasia"],"prefix":"10.1097","volume":"140","author":[{"given":"Kari L.","family":"Ring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Modesitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/2053369119833583","article-title":"Prevalence of hyperplasia and cancer in endometrial polyps in women with postmenopausal bleeding: a systematic review and meta-analysis","volume":"25","author":"Ghoubara","year":"2019","journal-title":"Post Reprod Health"},{"key":"R2-20260916","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: Cancer J Clin"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.12249","article-title":"Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification","volume":"64","author":"Ordi","year":"2014","journal-title":"Histopathology"},{"key":"R4-20260916","first-page":"1617","article-title":"Progression of endometrial hyperplasia: a revisit under the 2014 WHO classifications","volume":"9","author":"Wilson","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.27457","article-title":"Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan","volume":"131","author":"Lacey","year":"2012","journal-title":"Int J Cancer"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/(SICI)1096-9896(200003)190:4<462::AID-PATH590>3.0.CO;2-D","article-title":"Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry","volume":"190","author":"Mutter","year":"2000","journal-title":"J Pathol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0344-0338(11)80244-X","article-title":"Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features","volume":"188","author":"Baak","year":"1992","journal-title":"Pathol Res Pract"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00000478-200107000-00012","article-title":"Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias","volume":"25","author":"Baak","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.humpath.2005.02.018","article-title":"Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression","volume":"36","author":"Baak","year":"2005","journal-title":"Hum Pathol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000478-199504000-00001","article-title":"Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion","volume":"19","author":"Longacre","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0","article-title":"Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma","volume":"49","author":"Kurman","year":"1982","journal-title":"Cancer"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAP.0b013e3181919e15","article-title":"Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics","volume":"16","author":"McKenney","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00313020601146814","article-title":"Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis","volume":"39","author":"Rabban","year":"2007","journal-title":"Pathology"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00000478-200005000-00012","article-title":"Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis","volume":"24","author":"Soslow","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1746-1596-8-25","article-title":"Endometrial intraepithelial carcinoma in association with polyp: review of eight cases","volume":"8","author":"Yasuda","year":"2013","journal-title":"Diagn Pathol"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978\u20132013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"67","author":"M\u00f8ller","year":"2018","journal-title":"Gut"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","article-title":"Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies","volume":"3","author":"Ryan","year":"2017","journal-title":"JAMA Oncol"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","article-title":"Risks of less common cancers in proven mutation carriers with Lynch syndrome","volume":"30","author":"Engel","year":"2012","journal-title":"J Clin Oncol"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in Peutz\u2013Jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"598.e1","DOI":"10.1016\/j.ajog.2016.06.006","article-title":"Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women","volume":"215","author":"Wise","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/aje\/kwn168","article-title":"Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history","volume":"168","author":"Epplein","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2015.05.015","article-title":"Women at extreme risk for obesity-related carcinogenesis: baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life","volume":"138","author":"Modesitt","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","article-title":"Cancer risk and PCOS","volume":"78","author":"Dumesic","year":"2013","journal-title":"Steroids"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2014.01.004","article-title":"Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross-sectional study","volume":"132","author":"Shan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09513590.2012.706671","article-title":"Life-style and metformin for the prevention of endometrial pathology in postmenopausal women","volume":"29","author":"Campagnoli","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jamcollsurg.2009.01.045","article-title":"Cancer in obese women: potential protective impact of bariatric surgery","volume":"208","author":"McCawley","year":"2009","journal-title":"J Am Coll Surgeons"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial","volume":"10","author":"Sj\u00f6str\u00f6m","year":"2009","journal-title":"Lancet Oncol"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2013.11.012","article-title":"Bariatric surgery decreases the risk of uterine malignancy","volume":"133","author":"Ward","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R39-20260916","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2017.02.036","article-title":"Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study","volume":"145","author":"Anveden","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R40-20260916","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/1471-0528.12100","article-title":"Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study","volume":"120","author":"Argenta","year":"2013","journal-title":"BJOG"},{"key":"R41-20260916","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6605902","article-title":"Physical activity, sedentary behaviours, and the prevention of endometrial cancer","volume":"103","author":"Moore","year":"2010","journal-title":"Br J Cancer"},{"key":"R42-20260916","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ejca.2008.05.001","article-title":"Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors","volume":"44","author":"Linkov","year":"2008","journal-title":"Eur J Cancer"},{"key":"R43-20260916","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/AOG.0000000000004711","article-title":"Executive summary of the uterine cancer evidence review conference","volume":"139","author":"Chelmow","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R44-20260916","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","article-title":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study","volume":"149","author":"Jareid","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R45-20260916","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R46-20260916","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/13697137.2011.579650","article-title":"The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review","volume":"14","author":"Wan","year":"2011","journal-title":"Climacteric"},{"key":"R47-20260916","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1940-6207.CAPR-20-0248","article-title":"PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: a feasibility study","volume":"14","author":"Derbyshire","year":"2021","journal-title":"Cancer Prev Res"},{"key":"R48-20260916","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/AOG.0000000000001616","article-title":"Levonorgestrel intrauterine device as an endometrial cancer prevention strategy in obese women: a cost-effectiveness analysis","volume":"128","author":"Dottino","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R49-20260916","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","article-title":"Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev Res"},{"key":"R50-20260916","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000267500.27329.85","article-title":"Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families","volume":"110","author":"Chen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R51-20260916","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10689-009-9252-x","article-title":"Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome","volume":"8","author":"Gerritzen","year":"2009","journal-title":"Fam Cancer"},{"key":"R52-20260916","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/01443615.2018.1458081","article-title":"Thickened endometrium in asymptomatic postmenopausal women \u2013 determining an optimum threshold for prediction of atypical hyperplasia and cancer","volume":"38","author":"Ghoubara","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"R53-20260916","first-page":"260","article-title":"Outpatient endometrial sampling with the Pipelle curette","volume":"37","author":"Ben-Baruch","year":"1994","journal-title":"Gynecol Obstet Invest"},{"key":"R54-20260916","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.ajog.2010.05.004","article-title":"Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk","volume":"203","author":"Leitao","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R55-20260916","first-page":"400","article-title":"Hysteroscopy with directed biopsy versus dilatation and curettage for the diagnosis of endometrial hyperplasia and cancer in perimenopausal women","volume":"28","author":"BedneR","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"R56-20260916","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ygyno.2017.12.026","article-title":"The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia","volume":"148","author":"Touhami","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R57-20260916","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/AOG.0000000000002631","article-title":"The role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding. ACOG Committee Opinion No. 734. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R58-20260916","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaoncol.2021.1700","article-title":"Estimated performance of transvaginal ultrasonography for evaluation of postmenopausal bleeding in a simulated cohort of Black and White women in the US","volume":"7","author":"Doll","year":"2021","journal-title":"JAMA Oncol"},{"key":"R59-20260916","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jcu.22631","article-title":"Risk of endometrial cancer and endometrial hyperplasia with atypia in asymptomatic postmenopausal women with endometrial thickness \u226511 mm: a systematic review and meta-analysis","volume":"46","author":"Alc\u00e1zar","year":"2018","journal-title":"J Clin Ultrasound"},{"key":"R60-20260916","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/uog.1704","article-title":"How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding","volume":"24","author":"Smith-Bindman","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R61-20260916","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/uog.12306","article-title":"Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis","volume":"40","author":"Breijer","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R62-20260916","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2011.38.8645","article-title":"Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study","volume":"30","author":"Walker","year":"2012","journal-title":"J Clin Oncol"},{"key":"R63-20260916","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00432-016-2303-4","article-title":"FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?","volume":"143","author":"Papadia","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"R64-20260916","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/AOG.0000000000004352","article-title":"Uptake and outcomes of sentinel lymph node mapping in women with atypical endometrial hyperplasia","volume":"137","author":"Dioun","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R65-20260916","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","article-title":"Management of endometrial precancers","volume":"120","author":"Trimble","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R66-20260916","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/01.AOG.0000465189.50026.20","article-title":"Endometrial intraepithelial neoplasia. Committee Opinion No. 631. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R67-20260916","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/AOG.0b013e31828d6186","article-title":"Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma","volume":"121","author":"Hubbs","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R68-20260916","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1479-828X.2009.00981.x","article-title":"The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.","volume":"49","author":"Buttini","year":"2009","journal-title":"Aust New Zealand J Obstet Gynaecol"},{"key":"R69-20260916","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R70-20260916","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R71-20260916","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","article-title":"A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","author":"Shan","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"R72-20260916","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"R73-20260916","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/AOG.0000000000004170","article-title":"Adherence to oral anticancer therapeutics in the gynecologic oncology population","volume":"136","author":"Watson","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R74-20260916","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"key":"R75-20260916","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","article-title":"Prediction of regression and relapse of endometrial hyperplasia with conservative therapy","volume":"121","author":"Gallos","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R76-20260916","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R77-20260916","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R78-20260916","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2020.02.008","article-title":"The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia\/endometrial intraepithelial neoplasia or endometrial cancer: little impact on response and low live-birth rates","volume":"157","author":"Acosta-Torres","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R79-20260916","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"R80-20260916","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3390\/cancers13112847","article-title":"Molecular classification to prognosticate response in medically managed endometrial cancers and endometrial intraepithelial neoplasia","volume":"13","author":"Puechl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R81-20260916","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2017.04.006","article-title":"Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women","volume":"146","author":"Baker","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R83-20260916","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2017.07.120","article-title":"Effects of metformin on endometrial cancer: systematic review and meta-analysis","volume":"147","author":"Meireles","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R84-20260916","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1471-0528.16108","article-title":"Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial","volume":"127","author":"Yang","year":"2020","journal-title":"BJOG"},{"key":"R85-20260916","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/ijgc-2021-002699","article-title":"Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis","volume":"31","author":"Chae-Kim","year":"2021","journal-title":"Int J Gynecol Cancer"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:06:25Z","timestamp":1789556785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004989","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"2022-04-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}